From: HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens
HER2/CEP17ratio for surgically resected specimens
Number of tumors
HER2/CEP17ratio for CNB specimens
> 2.2
1.8 to 2.2
<1.8
Higher than 2.2
11
0
1
12
% agreement = 92%